⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Official Title: Phase II Evaluation of Three-Day Topotecan (NSC 609699) in Recurrent Platinum-Sensitive Ovarian or Primary Peritoneal Cancer

Study ID: NCT00005029

Study Description

Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of topotecan in treating patients who have recurrent ovarian epithelial or primary peritoneal cancer.

Detailed Description: OBJECTIVES: I. Determine the antitumor activity of topotecan in patients with recurrent platinum sensitive ovarian epithelial or primary peritoneal cancer. II. Determine the nature and degree of toxicity of this treatment regimen in these patients. OUTLINE: Patients receive topotecan IV over 30 minutes on days 1-3. Treatment continues every 3 weeks in the absence of disease progression or unacceptable toxicity. Patients are followed every 3 months for 2 years and then every 6 months for 3 years. PROJECTED ACCRUAL: A total of 22-60 patients will be accrued for this study.

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States

CCOP - Greater Phoenix, Phoenix, Arizona, United States

USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Chao Family Comprehensive Cancer Center, Orange, California, United States

Women's Cancer Center, Palo Alto, California, United States

University of Colorado Cancer Center, Denver, Colorado, United States

Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia, United States

Walter Reed Army Medical Center, Washington, District of Columbia, United States

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Emory University Hospital - Atlanta, Atlanta, Georgia, United States

MBCCOP - Hawaii, Honolulu, Hawaii, United States

MBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States

Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, United States

University of Chicago Cancer Research Center, Chicago, Illinois, United States

CCOP - Central Illinois, Decatur, Illinois, United States

CCOP - Evanston, Evanston, Illinois, United States

Indiana University Cancer Center, Indianapolis, Indiana, United States

CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States

Johns Hopkins Oncology Center, Baltimore, Maryland, United States

Medicine Branch, Bethesda, Maryland, United States

Radiation Oncology Branch, Bethesda, Maryland, United States

Tufts University School of Medicine, Boston, Massachusetts, United States

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States

CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

University of Minnesota Cancer Center, Minneapolis, Minnesota, United States

University of Mississippi Medical Center, Jackson, Mississippi, United States

Keesler Medical Center - Keesler AFB, Keesler Air Force Base, Mississippi, United States

Ellis Fischel Cancer Center, Columbia, Missouri, United States

CCOP - Kansas City, Kansas City, Missouri, United States

Washington University School of Medicine, Saint Louis, Missouri, United States

CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States

CCOP - Montana Cancer Consortium, Billings, Montana, United States

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States

Cooper Hospital/University Medical Center, Camden, New Jersey, United States

Cancer Center of Albany Medical Center, Albany, New York, United States

State University of New York Health Science Center at Brooklyn, Brooklyn, New York, United States

North Shore University Hospital, Manhasset, New York, United States

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

University of Rochester Cancer Center, Rochester, New York, United States

State University of New York Health Sciences Center - Stony Brook, Stony Brook, New York, United States

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States

Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Brookview Research, Inc., Winston-Salem, North Carolina, United States

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States

Barrett Cancer Center, The University Hospital, Cincinnati, Ohio, United States

Ireland Cancer Center, Cleveland, Ohio, United States

Cleveland Clinic Cancer Center, Cleveland, Ohio, United States

Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States

University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, United States

CCOP - St. Francis Hospital/Natalie Warren Bryant Cancer Center, Tulsa, Oklahoma, United States

CCOP - Columbia River Program, Portland, Oregon, United States

Abington Memorial Hospital, Abington, Pennsylvania, United States

Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States

Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

CCOP - MainLine Health, Wynnewood, Pennsylvania, United States

Medical University of South Carolina, Charleston, South Carolina, United States

CCOP - Greenville, Greenville, South Carolina, United States

CCOP - Upstate Carolina, Spartanburg, South Carolina, United States

CCOP - Baptist Cancer Institute, Memphis, Tennessee, United States

Simmons Cancer Center - Dallas, Dallas, Texas, United States

University of Texas - MD Anderson Cancer Center, Houston, Texas, United States

CCOP - Scott and White Hospital, Temple, Texas, United States

Cancer Center, University of Virginia HSC, Charlottesville, Virginia, United States

University of Washington Medical Center, Seattle, Washington, United States

Tacoma General Hospital, Tacoma, Washington, United States

NCIC-Clinical Trials Group, Kingston, Ontario, Canada

Contact Details

Name: David S. Miller, MD

Affiliation: Simmons Cancer Center

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: